19 completed, 2 terminated, 1 withdrawn. 22 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 22 | Completed 19, Terminated 2, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Lorazepam: new trials by email Literature Review of Lorazepam trials Research Report on Lorazepam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects LSD (150 µg) + ketanserin (40 mg), LSD (150 µg) + olanzapine (10 mg), LSD (150 µg) + lorazepam (2 mg) - Healthy | Phase 1 | Completed | University Hospital, Basel, Switzerland | 20 | 2024-02-01 | 2025-11-17 |
| Psilocybin for Treatment of Obsessive Compulsive Disorder Psilocybin 100 mcg/kg, Psilocybin 300 mcg/kg, Lorazepam 1 mg - Obsessive-compulsive Disorder (OCD) | Phase 1 | Completed | University of Arizona | 15 | 2019-01-02 | 2024-08-30 |
| Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free) Benzodiazepine - limited use strategy, Benzodiazepine - Ad libitum strategy - Post-operative Delirium | Phase 1 | Completed | McMaster University | 480 | 2017-04-01 | 2018-10-16 |
| Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas LMP744, Ondansetron, Olanzapine - Solid Tumors, Lymphoma | Phase 1 | Completed | National Cancer Institute (NCI) | 36 | 2017-02-27 | 2024-12-10 |
| Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity Oxytocin, Lorazepam 1 mg, Placebo nasalspray - Oxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of Drugs | Phase 1 | Completed | University Hospital, Bonn | 120 | 2016-03-03 | 2019-04-17 |
| Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects Lorazepam, Placebo - Healthy | Phase 1 | Completed | Pfizer | 8 | 2014-01-01 | 2014-03-03 |
| A First In Human Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Single Oral Doses Of PF-06372865 PF-06372865 or Placebo, PF-06372865 or Placebo or Lorazepam - Healthy | Phase 1 | Completed | Pfizer | 45 | 2013-10-01 | 2014-08-18 |
| Catatonia in Nodding Syndrome and Lorazepam Treatment Lorazepam - Catatonia, Nodding Syndrome | Phase 1 | Completed | Makerere University | 16 | 2013-03-01 | 2015-06-03 |
| The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms lorazepam - Alzheimer's Disease (AD) | Phase 1 | Completed | Mayo Clinic | 57 | 2013-01-01 | 2016-11-10 |
| A Study of the Effect of LY2216684 on Lorazepam LY2216684, Placebo, Lorazepam - Major Depressive Disorder | Phase 1 | Completed | Eli Lilly and Company | 28 | 2010-12-01 | 2019-03-11 |
| EEG (Electroencephalogram) Platform Standardization in Healthy Male Subjects (3134-010) MK3134, Comparator: Lorazepam, Comparator: Placebo - Dementia | Phase 1 | Completed | Merck Sharp & Dohme LLC | 25 | 2010-06-01 | 2015-11-02 |
| Study to Evaluate the Abuse Potential of AZD7325 in Healthy Recreational Central Nervous System (CNS) Depressant Users Lorazepam, AZD7325, Placebo - Recreational CNS Depressant Use | Phase 1 | Completed | AstraZeneca | 100 | 2009-05-01 | 2009-09-23 |
| How Your Patients' Non-REM Sleep Changes On Sedatives in the Intensive Care Units Dexmedetomidine, GABA agonist - Delirium, Respiratory Failure | Phase 1 | Terminated | Vanderbilt University Medical Center | 6 | 2009-01-01 | 2017-06-05 |
| A Sedation/Cognition/EEG Study Using AZD6280 and Comparator AZD6280, Lorazepam, Placebo - Healthy Volunteer | Phase 1 | Completed | AstraZeneca | 17 | 2008-09-01 | 2009-06-26 |
| Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam Brivaracetam, levetiracetam, lorazepam - Epilepsy | Phase 1 | Completed | UCB Pharma | 20 | 2008-07-01 | 2012-05-28 |
| A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator. AZD7325, Lorazepam - Healthy Volunteer | Phase 1 | Completed | AstraZeneca | 16 | 2008-06-01 | 2010-12-10 |
| A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects. placebo, lorazepam, GW876008 - Healthy Subjects | Phase 1 | Completed | GlaxoSmithKline | 26 | 2007-03-01 | 2010-10-15 |
| SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia [123]I-CNS 1261, Lorazepam, Risperidone - Schizophrenia | Phase 1 | Terminated | GlaxoSmithKline | 55 | 2005-07-01 | 2016-01-11 |
| Lorazepam for the Treatment of Status Epilepticus in Children lorazepam - Status Epilepticus | Phase 1 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 69 | 2005-03-01 | 2016-05-23 |
| Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg Lorazepam Tablets 2 mg, Ativan Tablets 2 mg - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 28 | 2004-12-01 | 2024-04-24 |
Showing 20 of 22. Sign in to see all of them.
Alzheimer Disease (1) · Anxiety Disorders (1) · Catatonia (1) · Delirium (1) · Dementia (1) · Depressive Disorder, Major (1) · Dysphonia (1) · Emergence Delirium (1) · Epilepsy (1) · Lymphoma (1) · Nodding Syndrome (1) · Obsessive-Compulsive Disorder (1) · Respiratory Insufficiency (1) · Schizophrenia (1) · Status Epilepticus (1)
AstraZeneca (3) · GlaxoSmithKline (2) · Pfizer (2) · Eli Lilly and Company (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Makerere University (1) · Mayo Clinic (1) · McMaster University (1) · Merck Sharp & Dohme LLC (1) · Mylan Pharmaceuticals Inc (1) · National Cancer Institute (NCI) (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · UCB Pharma (1) · University Hospital, Basel, Switzerland (1) · University Hospital, Bonn (1)
United States (10) · Netherlands (3) · Canada (2) · Germany (1) · Japan (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Alice P Chen, M.D. (1) · Angelina Kakooza-Mwesige, MMed (1) · Cynthia Stonnington, MD (1) · Dirk M Dhossche, MD, PhD (1) · Dorian Williams, M.D. (1) · Francisco A. Moreno, MD (1) · James Chamberlain, MD (1) · Karen Miotto, M.D. (1) · Myroslava K Romach, MD (1)
PMID 17196053, PMID 20887370, PMID 26710961, PMID 29671186, PMID 32416996, PMID 40439882, PMID 41825921
K23DA014291 (1)